Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment
Ling Yang, Qian Ning, Shengsong Tang
Journal of Immunology Research (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Immune-related adverse events of immune checkpoint inhibitors: a review
Qinan Yin, Liuyun Wu, Lizhu Han, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 111
The future of affordable cancer immunotherapy
Niels Schaft, Jan Dörrie, Gerold Schuler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 33
New immunotherapeutic approaches for cancer treatment
Amin Kamrani, Ramin Hosseinzadeh, Navid Shomali, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154632-154632
Closed Access | Times Cited: 26
Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine
Nadia Μ. Hamdy, Emad B. Basalious, Mona G. El-Sisi, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 11, pp. 1943-1961
Closed Access | Times Cited: 8
Research progress on the impact of intratumoral microbiota on the immune microenvironment of malignant tumors and its role in immunotherapy
Jiamei Xu, Min Cheng, Jie Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
Violeta Delgado-Almenta, José L. Blaya-Cánovas, Jesús Calahorra, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 216-216
Open Access
Biomimetic Nanoparticle Based Targeted mRNA Vaccine Delivery as a Novel Therapy for Glioblastoma Multiforme
Tanvir Ahmed, Kazi Tasnuva Alam
AAPS PharmSciTech (2025) Vol. 26, Iss. 3
Closed Access
Limitations of Immunotherapy in Cancer
Sanya Gupta, Samarth Shukla
Cureus (2022)
Open Access | Times Cited: 26
Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light
Jie Zhang, Kang-Hui Wu, Cuicui Shi, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 12, pp. 1777-1792
Open Access | Times Cited: 24
Advances in immunotherapy for biliary tract cancers
Yuhao Zhao, Mao Yang, Jiayi Feng, et al.
Chinese Medical Journal (2023) Vol. 137, Iss. 5, pp. 524-532
Open Access | Times Cited: 11
Clinical characteristics and novel strategies of immune checkpoint inhibitor rechallenge therapy for non-small cell lung cancer: a comprehensive review
Hao Zhang, Yujun Hu, Tingting Wu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Cancer Biology and Therapeutics: Navigating Recent Advances and Charting Future Directions

Tropical Journal of Natural Product Research (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 8
A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends, collaborations, and future avenues
Yi‐Hsiang Huang, Chengxiao Liao, Zefeng Shen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Discovery of Pyridine-2-Carboxamides Derivatives as Potent and Selective HPK1 Inhibitors for the Treatment of Cancer
Jingjing Peng, Xiaoyu Ding, Celia Y. Chen, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
The Present and Future of Clinical Management in Metastatic Breast Cancer
Pauline H. Lin, George Laliotis
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5891-5891
Open Access | Times Cited: 12
Cold atmospheric plasma-induced oxidative stress and ensuing immunological response – a Neo-Vista in immunotherapy
Sreedevi P. R, K. Suresh, S. Yugeswaran
Free Radical Research (2022) Vol. 56, Iss. 7-8, pp. 498-510
Closed Access | Times Cited: 12
Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response
Reem Youssef, Rohan Maniar, Jaffar M. Khan, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 12, pp. 9753-9767
Open Access | Times Cited: 7
Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context
Justyna Czapla, Alina Drzyzga, Sybilla Matuszczak, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Hydroxyapatite-based carriers for tumor targeting therapy
Gongming Qian, Lingya Xiong, Qing Ye
RSC Advances (2023) Vol. 13, Iss. 24, pp. 16512-16528
Open Access | Times Cited: 5
Identification of PDZD11 as a Potential Biomarker Associated with Immune Infiltration for Diagnosis and Prognosis in Epithelial Ovarian Cancer
Xiaoqi Chen, Zhuang Li, Yanying Feng, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 2113-2128
Open Access | Times Cited: 1
Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development
Yiyuan Feng, Caiying He, Chang Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6444-6444
Open Access | Times Cited: 1
Molecular mechanisms underlying the modulation of T-cell proliferation and cytotoxicity by immobilized CCL21 and ICAM1
Sofi Yado, Bareket Dassa, Rawan Zoabi, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e009011-e009011
Open Access | Times Cited: 1
Nanoengineered Platform-Based Microenvironment-Triggered Immunotherapy in Cancer Treatment
Namdev Dhas, Ritu Kudarha, Sanjay Kulkarni, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 10
Open Access | Times Cited: 1
Activation of cancer immunotherapy by nanomedicine
Lijuan Wang, Henan Xu, Lili Weng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
Konstantinos Ouranos, Anthi Chatziioannou, Ioannis Goulis, et al.
World Journal of Transplantation (2022) Vol. 12, Iss. 11, pp. 331-346
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top